Cargando…
Statins and SARS-CoV-2 disease: Current concepts and possible benefits
BACKGROUND AND AIMS: Inflammation-mediated tissue injury is the major mechanism involved in the pathogenesis of coronavirus disease 2019 (COVID-2019), caused by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Statins have well-established anti-inflammatory, anti-thrombotic and immuno-m...
Autores principales: | Minz, Madhu Mary, Bansal, Manish, Kasliwal, Ravi R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582042/ https://www.ncbi.nlm.nih.gov/pubmed/33120281 http://dx.doi.org/10.1016/j.dsx.2020.10.021 |
Ejemplares similares
-
The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed
por: Bifulco, Maurizio, et al.
Publicado: (2020) -
Carotid intima–media thickness: Current evidence, practices, and Indian experience
por: Kasliwal, Ravi R., et al.
Publicado: (2014) -
Optimum cardiovascular risk prediction algorithm for South-Asians – Are WHO risk prediction charts really the right answer?
por: Bansal, Manish, et al.
Publicado: (2016) -
Heme, Heme Oxygenase-1, Statins, and SARS-CoV-2
por: Stevenson, David K., et al.
Publicado: (2023) -
Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies
por: Suresh, Voddu, et al.
Publicado: (2021)